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Abstract 
BACKGROUND: Preeclampsia is one of the commonest aetiologies of foetal and maternal mortality and 
morbidity. Though common, the aetiology of preeclampsia has remained unknown with several inconclusive 
theories surrounding the disease. Recent studies have implicated vascular endothelial dysfunction and possibly 
nitric oxide in preeclampsia.  
AIM: To compare plasma nitric oxide levels in pre-eclampsia and healthy pregnant women in a large tertiary 
hospital in Ghana. 
METHODS: This was a case-control study conducted among pre-eclampsia and healthy pregnant women in 
Korle-Bu Teaching Hospital over a four-month period. Thirty (30) pre-eclamptic and 30 healthy pregnant women 
aged 18-35 years with over 30 weeks’ gestation were consecutively recruited into the study after obtaining 
informed consent. Plasma nitric oxide levels were determined using the Griess Reagent system.  Data were 
analysed using Statistical Package for the Social Sciences (SPSS) software version 20.0 and results were 
compared using the independent t-test. A P-value of ≤ 0.05 was considered statistically significant. 
RESULTS: The parity and body mass index (BMI) of the participants were similar. There was a significant 
difference in the blood pressure of the pre-eclamptic compared to healthy pregnant women. There was no 
statistically significant difference (P-value = 0.160) in the plasma levels of nitric oxide in pre-eclamptic (Mean = 
1178.78; SD = 89.70 nM) compared to healthy pregnant women (Mean = 1365.43; SD = 95.46 nM).  
CONCLUSION: Plasma nitric oxide levels may not play a significant role in the aetiology of pre-eclampsia. 
 
 
 
 
 
 
Introduction 
 
Two to eight per cent (2-8%) of all 
pregnancies worldwide are complicated by pre-
eclampsia causing over 63,000 maternal deaths 
annually [1]. The maternal mortality rate of pre-
eclampsia is highest in low and middle income 
countries. However, pre-eclampsia is still a life-
threatening disorder even in developed countries [2]. 
There is a five-fold increase in perinatal deaths from 
intrauterine growth restriction and prematurity as a 
result of pre-eclampsia [3]. Preterm birth in itself is 
responsible for the majority of neonatal deaths and 
nearly one half of all cases of congenital neurologic 
disability [4]. Fifteen percent (15%) of all premature 
deliveries in the United States (US) are as a result of 
pre-eclampsia [3]. The aetiology of pre-eclampsia lies 
in the placenta though it remains unknown [5]. Pre-
eclampsia is known to occur only in the presence of a 
placenta as in for example molar pregnancy and 
resolves after its delivery. Placental growth is a 
regulated process and it is vital for normal foetal 
development and for maintenance of successful 
pregnancy. Normal placental development requires 
that cytotrophoblast invades the maternal spiral 
arterioles [5]. There is an impairment of 
cytotrophoblastic invasion of the myometrial portion of 
the spiral arteries in pre-eclampsia leading to 
narrowing of the spiral arteries with limited blood 
supply to the foetus [6]. This eventually causes 
placental ischaemia and microinfarction with 
subsequent release of placental factors leading to an 
imbalance in angiogenic factors and therefore 
widespread endothelial dysfunction that is seen in pre-
eclampsia [6]. The ability of the maternal system to 
handle the deficits in placentation and subsequent 
challenge to the maternal cardiovascular system 
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partly depend on the immune system, as systemic 
inflammatory stress plays a key role in endothelial cell 
activation [6].  
Nitric oxide (NO), a vascular endothelial 
relaxant may be involved in the development of pre-
eclampsia. An endothelial form of NO synthase has 
been localised to the syncytiotrophoblast and villous 
endometrium in term pregnancies [5] [6]. The placenta 
is, therefore, an important source of NO during 
pregnancy. Various animal models in which NO 
synthesis has been inhibited have been associated 
with symptoms such as hypertension, proteinuria, 
thrombocytopenia and restricted foetal growth [5] [6]. 
The main placental vasodilator is nitric oxide, and it 
regulates placental vascular resistance and reactivity, 
apoptosis and invasion by trophoblast, and 
aggregation and adhesion of platelets in the placental 
bed [7]. Numerous studies hold the view that pre-
eclampsia is a multisystem disorder with vascular 
endothelial dysfunction, however, as to whether the 
change in the function of the endothelium noted in 
pre-eclampsia results in a decrease, an increase or an 
unchanged endothelial NO synthesis is still debatable 
[8].  
Literature has reported inconsistent results as 
far as serum nitric oxide levels in pre-eclampsia 
compared to healthy pregnant women is concerned. 
Various studies have reported raised serum nitric 
oxide levels [9] while others have reported non-
significant change [8] [10], and others too, a reduced 
serum level of nitric oxide [5] [6] [11] in pre-eclampsia 
compared to normal pregnant women. There is also 
conflicting literature as to whether the alteration in the 
function of the endothelium seen in pre-eclampsia 
results in a pathophysiologic decrease in NO 
synthesis [8] [10]. Notwithstanding the above 
controversies, systematic reviews and meta-analyses 
have shown that pre-eclamptic have a significant 
increased risk of incidence of cardiovascular 
diseases, obesity, diabetes and insulin resistance 
later in life [12]. Thus pre-eclampsia has a huge global 
and economic burden. There is, therefore, the need to 
carry out this study to find out the role NO play in the 
pathophysiology of pre-eclampsia in Ghanaian 
women. 
 
 
Methods 
 
This was a case-control study undertaken at 
the Korle-Bu Teaching Hospital (KBTH), Ghana 
between March and June 2016.  
The study was conducted at the Korle-Bu 
Teaching Hospital, the premiere Teaching Hospital 
and the largest tertiary hospital affiliated with the 
University of Ghana School of Medicine and Dentistry. 
The 2000 bed capacity hospital has a 350 bed 
capacity with 3 operating theatre suites obstetrics and 
gynaecology department. The department has 65 
doctors, 200 nurses and midwives, with a daily 
antenatal attendance of 100 patients, and a total 
annual delivery of between 10,000 and 12,000. 
Ethical Approval for the study was obtained 
from the Ethical and Protocol Review Committee of 
University of Ghana School of Medicine and Dentistry 
(Protocol Identification Number: CHS-Et/M.4-
P4.5/2015-2016). Clearance was also received from 
the Management of the Korle-Bu Teaching Hospital 
and Head of Obstetrics and Gynaecology department 
where the study was conducted. 
The study population included third-trimester 
healthy pregnant women and pre-eclamptics aged 18-
35 years attending the obstetrics and gynaecology 
clinic at the Korle-Bu Teaching Hospital. Patients not 
eligible for inclusion were: 
1. Pregnant and pre-eclamptic on any 
medical treatment other than iron and folic acid 
2. Pregnant and pre-eclamptic with 
chronic hypertension, history of kidney disease, 
diabetes mellitus, cardiac diseases and 
neuromuscular problems.  
Pre-eclampsia was diagnosed using the onset 
of hypertension after 20 weeks of gestation with blood 
pressure > 140/90 mmHg measured on two separate 
occasions with the coexistence of proteinuria of at 
least 2+ on dipstick [13].  
The plasma nitric oxide level for healthy 
pregnant women and pre-eclamptics has been found 
to be 63.8 and 73.3 μmol/l respectively [14], with a 
mean difference (d) of 9.5 μmol/l. Using the formula 
by Charan and Biswas [15], sixty (60) pregnant 
women in their third trimester (gestation > 30 weeks), 
consisting of 30 pre-eclamptic as cases and 30 
healthy pregnant women as controls were recruited 
consecutively into the study after obtaining informed 
consent.  
The participants were interviewed using a 
structured questionnaire to obtain their demographic 
characteristics after signing an informed consent form. 
The information collected included their age, parity 
and gestational age. Participants subsequently had 
their weight and height measured using mechanical 
patient weighing scale with height rod (Product: 6003, 
Italy). 
Three ml of blood was drawn from the cubital 
vein using a sterile 19G hypodermic needle fixed on a 
5 ml syringe after cleansing the site to be punctured 
with methylated spirit. Aseptic conditions were 
adhered to. The blood sample was transferred into a 
sodium ethylenediamine tetraacetate (Na EDTA) test 
tube and prevented from clotting by gently inverting 
the tube 4 times manually. Nitric oxide levels were 
assessed in the plasma samples using the Griess 
Reagent system (Promega, Madison, USA). The 
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assay relies on a diazotisation reaction that was 
originally described by Griess in 1879.  
Patients’ age, weight, height, parity, BMI and 
plasma nitric oxide levels were entered into Microsoft
®
 
Access database 2010 (Microsoft
®
 USA), and analysis 
was done using statistical package for social science 
(SPSS
®
) software version 20.0. 
The age, BMI and parity of participants, were 
presented as means (standard deviations) in a tabular 
form. The plasma nitric oxide levels between the two 
groups were presented in a bar chart. Independent t-
test was employed to compare the difference between 
the mean plasma nitric oxide level of pre-eclamptic 
and healthy pregnant women. A p-value ≤ 0.05 was 
considered statistically significant. 
 
 
Results 
 
The mean systolic, diastolic and arterial 
pressures were high in the pre-eclamptic compared to 
healthy pregnant women (Table 1). Age, parity and 
BMI were similar among the pre-eclamptic and the 
healthy pregnant women. 
Table 1: Demographic and clinical characteristics of the study 
sample 
Characteristic 
Pre-eclamptic 
Healthy pregnant 
women P-value 
Mean(SD) Mean(SD) 
N 30 30  
Age (years) 30.97 (5.51) 29.93 (2.60) 0.358 
Parity           1.70 (1.42) 1.13 (1.41) 0.567 
BMI 32.03 (7.52) 30.50 (5.50) 0.374 
SBP 170.13 (23.69) 116.47 (13.38) <0.001* 
DBP 106.30 (18.79) 67.57 (8.54) <0.001* 
MAP 126.20 (20.86) 83.87 (8.85) <0.001* 
*Significant at P < 0.05; n-sample size; SD-standard deviation; BMI-body mass index 
(kg/m
2
); SBP-systolic blood pressure (mmHg); DBP-diastolic blood pressure (mmHg); 
MAP-mean arterial pressure (mmHg). 
 
There was no statistically significant 
difference in plasma nitric oxide levels in pre-
eclamptic compared to healthy pregnant women (P = 
0.160). The plasma nitric oxide levels in pre-eclamptic 
and healthy pregnant women were 1178.78 (89.70) 
nM and 1365.43 (95.46) nM respectively (Figure 1). 
 
Figure 1: Mean plasma nitric oxide levels for pre-eclamptic and 
healthy pregnant women 
 
A non-significant negative correlation between 
mean arterial pressure and plasma nitric oxide levels 
in pre-eclamptic was noted (Pearson Correlation 
Coefficient r = -0.072; P = 0.712) (Figure 2). 
 
Figure 2: Correlation between mean arterial pressure and plasma 
nitric oxide levels in pre-eclamptic 
 
 
Discussion 
 
This study showed a statistically non-
significant difference (P = 0.358) between the 
maternal age of pre-eclamptic compared to healthy 
pregnant women and therefore no association of 
maternal age with pre-eclampsia. This is similar to the 
findings of other studies [16] but disagrees with the 
findings of Macdonald-Wallis and colleagues [17]. The 
difference in findings may be attributable to sample 
characteristic differences between the study 
populations.  
This study observed a statistically non-
significant difference (P = 0.374) in BMI between pre-
eclamptic and healthy pregnant women. Therefore 
BMI may have no association with pre-eclampsia. This 
is similar to the findings of Onyebule and colleagues 
[18] but contradicts the observations of other studies 
which have noted an association of elevated BMI with 
pre-eclampsia [19].  
The systolic, diastolic and mean arterial 
pressures of the pre-eclamptic were significantly 
higher compared to that of the healthy pregnant 
women (P < 0.001). This was expected given the 
criteria used for diagnosis of pre-eclampsia. Mean 
arterial pressure is said to be predictive of pre-
eclampsia even though other studies have noted 
otherwise [20].  
Our study showed a statistically non-
significant reduction in plasma nitric oxide levels in 
pre-eclamptic compared to healthy pregnant women 
(P = 0.160) agreeing with the observations of other 
studies [8] [10]. Previous studies designed to search 
for a relationship between nitric oxide production in 
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pre-eclampsia and healthy pregnancy has shown 
inconsistent conclusions [9] [11]. The supporters for 
increased nitric oxide levels in pre-eclamptic 
compared to healthy pregnant women argue that the 
increase is as a result of a compensatory mechanism 
for the occurring endothelial damage in pre-eclampsia 
hence an attempt to correct the vasospasm effect.  
However, the supporters for decreased nitric 
oxide levels in pre-eclamptic as compared to healthy 
pregnant women suggest that the reduction is as a 
result of down-regulation of the nitric oxide synthase 
enzyme and/or occurrence of endothelial damage in 
the development of the disorder. The results of a 
statistically non-significant difference in plasma nitric 
oxide levels between pre-eclamptic and healthy 
pregnant women in this study is supported by other 
studies [8] [10]. This finding, however, may not mean 
that there is no association between plasma nitric 
oxide levels and pre-eclampsia but then as per this 
study, the change in nitric oxide level may not 
significantly impact the pathophysiology of pre-
eclampsia. This may be because the determination of 
nitric oxide levels is confounded by several factors 
including a source of sample (plasma, serum, urine), a 
method of assaying, diet, alcohol consumption, 
atmospheric pollution, exercise and cigarette smoking 
[21].  
In disorders where there may be a very small 
difference in nitric oxide production, it may be 
impossible to find a significant change over the 
uncontrolled external factors stated above. 
Considering the study site, it may be very difficult 
eliminating the above inter-subject variations, and 
therefore a longitudinal study on selected subjects 
where inter/intra personal variations can be seen as 
well as any differences in nitric oxide levels 
throughout pregnancy between pre-eclamptic and 
healthy pregnant women is advised. Other studies 
have also admitted the contradictory reports regarding 
the involvement of nitric oxide in maternal adaptation 
to pregnancy and suggested possible multi-
mechanism physiology acting in concert to maintain 
the pregnant mother and the foetus with the input from 
each mechanism being genetically determined [22].  
A non-significant (P = 0.712) negative 
correlation (Pearson correlation coefficient r = -0.072) 
was found between mean arterial pressure and 
plasma nitric oxide levels of pre-eclamptic with an R
2
 
value of 0.5% implying that changes in plasma nitric 
oxide levels are a poor predictor of mean arterial 
pressures in pre-eclamptic patients.  
In conclusion, this study failed to demonstrate 
any significant difference in plasma nitric oxide levels 
in pre-eclamptic compared to healthy pregnant 
women. Therefore, plasma nitric oxide levels may not 
play a significant role in the pathophysiology of pre-
eclampsia.  
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